-
Recent Posts
- Dementia-Friendly Communities Provision, Viewed as a Social Determinant of Health (JGCR / NHS England / WHO)
- International Perspectives on the Possible Impact of the COVID-19 Pandemic and Lockdown on Abuse of the Elderly (JGCR / American Journal of Geriatric Psychiatry / JAGS)
- Updates Relating to the Lancet Commission on Dementia Prevention, Intervention, and Care (Lancet / Alzheimer’s Research and Therapy / Alzheimer’s and Dementia)
- A Brief Review of How the COVID-19 Pandemic Relates to Elderly Care and Research (JGCR)
- Some Speculated / Potential Benefits of COVID-19 (JGCR / BBC Radio 4’s Rethink / BGS)
Archives
- September 2020
- August 2020
- June 2020
- April 2020
- March 2020
- February 2020
- January 2020
- December 2019
- November 2019
- October 2019
- September 2019
- August 2019
- July 2019
- June 2019
- May 2019
- April 2019
- March 2019
- February 2019
- January 2019
- December 2018
- November 2018
- October 2018
- September 2018
- August 2018
- July 2018
- June 2018
- May 2018
- April 2018
- March 2018
- February 2018
- January 2018
- December 2017
- November 2017
- October 2017
- September 2017
- August 2017
- July 2017
- June 2017
- May 2017
- April 2017
- March 2017
- February 2017
- January 2017
- December 2016
- November 2016
- October 2016
- September 2016
- August 2016
- July 2016
- June 2016
- May 2016
- April 2016
- March 2016
- February 2016
- January 2016
- December 2015
- November 2015
- October 2015
- September 2015
- August 2015
- July 2015
- June 2015
- May 2015
- April 2015
- March 2015
- February 2015
- January 2015
- December 2014
- November 2014
- October 2014
- September 2014
- August 2014
- July 2014
- June 2014
- May 2014
- April 2014
- March 2014
- February 2014
- January 2014
- December 2013
- November 2013
- October 2013
- September 2013
- August 2013
- July 2013
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
Categories
- Antipsychotics
- Assistive Technology
- Charitable Bodies
- Commissioning
- Delirium
- Depression
- Enhancing the Healing Environment
- Falls
- Falls Prevention
- Guidelines
- Hip Fractures
- Housing
- Hypertension
- In the News
- Integrated Care
- International
- Local Interest
- Mental Health
- Models of Dementia Care
- National
- ADASS
- All-Party Parliamentary Group (APPG) on Dementia
- BSI
- CQC: Care Quality Commission
- Department of Health
- Department of Health and Social Care (DHSC)
- Health Education England (HEE)
- Housing LIN
- MAGDR
- Mental Health Foundation
- Mental Health Network (NHS Confederation)
- MHP Health Mandate
- National Audit Office
- National Voices
- NEoLCIN
- NEoLCP
- NHS
- NHS Alliance
- NHS Confederation
- NHS Employers
- NHS England
- NHS Evidence
- NHS Improvement
- NICE Guidelines
- NIHR
- NIHRSDO
- Northern Ireland
- Patients Association
- Public Health England
- RCN
- Royal College of Physicians
- Royal College of Psychiatrists
- SCIE
- Scotland
- UK
- UK NSC
- Wales
- Non-Pharmacological Treatments
- Nutrition
- Pain
- Parkinson's Disease
- Patient Care Pathway
- Person-Centred Care
- Personalisation
- Pharmacological Treatments
- Proposed for Next Newsletter
- Quick Insights
- Standards
- Statistics
- Stroke
- Systematic Reviews
- Telecare
- Telehealth
- Universal Interest
Google Translate (100+ Languages)
Tag Archives: Parkinson’s UK
Smell Test for Early Detection of Parkinson’s Disease (BBC News)
Summary Parkinson’s Disease has a distinctive odour for certain gifted individuals, which has been analysed chemically and may now be replicated for automated detection by machine. This may, in future, permit earlier diagnosis and open the possibilities for timely treatments … Continue reading
Posted in BBC News, Diagnosis, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, Parkinson's Disease, Quick Insights, Scotland, UK, Universal Interest
Tagged ACS Central Science (Journal), Anatune (Cambridge UK), BBC Health News, BBC Scotland News, Biomarkers, Biomarkers Predicting Parkinson's Disease, Department of Biochemistry: University of Liverpool, Department of Neurology: Salford Royal Foundation Trust, Early Diagnosis, Early Diagnosis of Parkinson’s Disease, Edinburgh University, Eicosane, Hyperosmic Super Smeller, Institute for Stem Cell Research: University of Edinburgh, Institute of Integrative Biology: University of Liverpool, Joy Milne, Les Milne, Manchester Academic Health Science Centre: University of Manchester, Neurodegeneration, Neurodegenerative Disease Research, Neurodegenerative Diseases, Non-Invasive Biomarkers, Odour, Parkinson's Disease Smell Test, Parkinson’s Disease Sebum Volatilome, Parkinson’s UK, Perillic Aldehyde, Rapid Screening, Salford Royal Foundation Trust, School of Biological Sciences: University of Edinburgh, Sebum, Smell Test for Parkinson's Disease Diagnosis, Timely / Preclinical Parkinson's Disease Diagnosis, Timely Diagnosis, University of Edinburgh, University of Liverpool, University of Manchester, Volatile Biomarkers of Parkinson’s Disease, Volatilome
Leave a comment
Updated Compendium of Patient Information on Parkinson’s Disease (Michael J. Fox Foundation / Parkinson’s UK)
Summary It is two years since the previous version of this collection, and some significant new patient guides have come to light, from both the USA and the UK. The Michael J. Fox Foundation for Parkinson’s Research offers an interesting … Continue reading
Posted in Charitable Bodies, Diagnosis, For Carers (mostly), For Nurses and Therapists (mostly), International, Management of Condition, Non-Pharmacological Treatments, Parkinson's Disease, Patient Information, Person-Centred Care, Personalisation, Pharmacological Treatments, Practical Advice, Quick Insights, UK, Universal Interest
Tagged Advice and Information, Amantadine, Anticholinergic Drugs, Anticholinergics, Carbidopa, Caregiving (Carers), Carer's Allowance, Complementary and Alternative Therapies for Parkinson’s Disease, Decarboxylase Inhibitor, Deep Brain Stimulation, Deep Brain Stimulation (DBS), Deep Brain Stimulation in Parkinson's Disease, Diet and Parkinson's Disease, Dopamine Agonists, Dopamine Releaser / Antiglutamatergic Medication, Drug Treatments for Parkinson's: Parkinson’s UK, Incontinence, Information and Advice Services, Information and Signposting Services, Information Needs of Carers, Information Needs of Patients, Living Well With Parkinson's Disease, Local Group Finance Guide: Parkinson’s UK, MAO-B Inhibitors, Michael J. Fox Foundation for Parkinson’s Research, Navigating Parkinson's Disease, NHS Evidence, Nocturia, Orthostatic Hypotension, Parkinson's Disease Psychosis, Parkinson’s 360º: Michael J. Fox Foundation, Parkinson’s Disease Dementia, Parkinson’s Disease Medications, Parkinson’s Disease: Complementary and Alternative Therapies, Parkinson’s Disease: Motor Medications and Associated Complications in Early - Middle Years, Parkinson’s Disease: Motor Medications and Associated Complications in Middle - Advancing Years, Parkinson’s Disease: Non-Motor Medications, Parkinson’s UK, Parkinson’s UK (Parkinsons Disease Society), Parkinsonian Symptoms, Participation in Research, Patient Involvement in Research, Public Participation in Research, Real Talk for Patients and Families (Michael J. Fox Foundation), Signposting, Signposting Patient Information, Signposting Services and Knowledge, Signposting to Sources of Practical Help, Tremor and Parkinson's Disease, Tremor and Parkinson's: Parkinson’s UK Fact Sheet No.94, Urinary Incontinence in Neurological Disease, USA, Using Computers and the Internet : Parkinson’s UK Fact Sheet No. FS60, Voices of People Living With Parkinson's Disease
Leave a comment
Parkinson’s Disease Awareness Week 2017 (BBC News / Nature Biotechnology / Parkinson’s UK)
Summary Researchers hope one day to be able to replace the damaged dopamine-producing neurons at the root-cause of by Parkinson’s Disease by injecting new replacement brain cells, possibly derived from re-programmed astrocytes. Full Text Link Reference Brain cell therapy ‘promising’ … Continue reading
Posted in Animal Studies, BBC News, Charitable Bodies, In the News, International, Person-Centred Care, Quick Insights, UK, Universal Interest
Tagged Ageing Population, Astrocytes, Austria, Awareness and Campaigns, Awareness and Understanding, Awareness Campaigns, Awareness Raising, BBC Health News, Biomedical Research Institute of Malaga (IBIMA), Cell Replacement Therapy for Neurodegenerative Diseases, Center for Brain Research: Medical University of Vienna, Department of Medical Biochemistry and Biophysics: Karolinska Institutet, Department of Molecular Neurosciences: Medical University of Vienna, Department of Neuroscience: Karolinska Institutet, Department of Pharmacology: Malaga University, Dopamine, Dopamine Neuron Degeneration, Faculty of Medicine: Malaga University, Induced Dopamine Neurons (iDANs), Induced Neurons (iNs), Induced Pluripotent Stem (iPS) Cells, Karolinska Institute, Karolinska Institute in Stockholm, Karolinska Institutet, Laboratory of Molecular Neurobiology: Karolinska Institutet, Malaga University, Medical University of Vienna, Midbrain Dopamine Neurons (mDAs), Nature Biotechnology (Journal), Neurodegenerative Disease Research, Neurodegenerative Diseases, Neurodegenerative Disorders, Parkinson's Awareness Month, Parkinson's Awareness Week, Parkinson’s Awareness Week (2017), Parkinson’s Disease Awareness Week (2017), Parkinson’s UK, Parkinson’s UK (Parkinsons Disease Society), Professor David Dexter: Parkinson's UK, Spain Institute for Stem Cell Biology and Regenerative Medicine: Stanford University, Stanford University, Substantia Nigra, Sweden, United States, USA, World Parkinson’s Day
Leave a comment
Earlier Diagnosis of Parkinson’s Disease? (BBC News / Acta Neuropathologica Communications)
Summary Recent animal research, using rats, suggests there may be a cheap and non-invasive method of detecting Parkinson’s Disease early – before symptoms develop – by identifying changes in the eye. The same study also offers early evidence for a … Continue reading
Posted in Animal Studies, BBC News, Diagnosis, For Doctors (mostly), For Researchers (mostly), In the News, Parkinson's Disease, Pharmacological Treatments, Quick Insights, UK
Tagged Acta Neuropathologica Communications, BBC Health News, Belgium, Biomarkers, DARC: Detection of Apoptosing Retinal Cells, Department of Biology: University of Leuven, Department of Surgery and Cancer: Imperial College London, Drug Discovery Programmes, Early Diagnosis, Early Diagnosis of Parkinson’s Disease, Eye Test to Detect Parkinson's Disease, Faculty of Medicine: Imperial College London, HEYEX® Thickness Map Analysis (Heidelberg Engineering), Imperial College Healthcare NHS Trust, Imperial College London, Imperial College Ophthalmology Research Group (ICORG): Imperial College London, Liposomal Formulation of PPAR-γ (Peroxisome Proliferator-Activated Receptor Gamma) Agonist Rosiglitazone, Liposome-Encapsulated Rosiglitazone, Loss of Dopaminergic Neurons in pars compacta of Substantia Nigra (SNpc), Neural Circuit Development and Regeneration Research Group: University of Leuven, Neurodegeneration, Neurodegenerative Disease Research, Neurodegenerative Diseases, Neurodegenerative Disorders, Neurodegenerative Research, Neuroprotective Agents, Neuroprotective Effect of Rosiglitazone, Nigrostriatal Neurons, Non-Invasive Biomarkers, Ocular Manifestations in Neurodegenerative Diseases, Parkinson’s UK, Preclinical Biomarkers in Parkinson's Disease, Rats, Retina as Early Biomarker of Neurodegeneration, Retinal Assessments Using DARC (Detection of Apoptosing Retinal Cells), Retinal Biomarkers, Retinal Changes as Surrogate Biomarker for Parkinson's Disease, Retinal Ganglion Cells (RGCs), Retinal Manifestations of Parkinson's Disease, Retinal Thickness, Rosiglitazone, Rotenone-Induced Model of Parkinson's Disease, School of Pharmacy: University of London, Substantia Nigra, Surrogate Biomarkers of Neurodegeneration, UCL Institute of Ophthalmology: University College London, University College London (UCL), University of Leuven, Western Eye Hospital: Imperial College Healthcare NHS Trust
Leave a comment
Lancet Seminar on Parkinson’s Disease (Lancet / Advances in Integrative Medicine / Translational Proteomics / Parkinson’s UK / BBC News)
Summary Coinciding with Parkinson’s Awareness Week 2015 (April 20th – 26th 2015), the following Lancet review / seminar covers the clinical features, risk factors, pathology, genetics, pathogenesis, diagnosis and treatment of Parkinson’s Disease. Full Text Link (Note: This article requires … Continue reading
Posted in Acute Hospitals, BBC News, Charitable Bodies, Community Care, Diagnosis, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, International, Management of Condition, Non-Pharmacological Treatments, Parkinson's Disease, Pharmacological Treatments, Quick Insights, Scotland, Systematic Reviews, UK, Universal Interest
Tagged Abnormal Prion Protein, Abnormal Proteins (Alpha-Synuclein), Abnormal Proteins (Prions), Acting Out Dreams: Rapid Eye Movement (REM) Sleep Behaviour Disorder, Advances in Integrative Medicine, Association of RBD with Synucleinopathies, BBC Health News, Biomarkers, Braak Model, Braak Staging of Lewy Pathology in Parkinson’s Disease, Canada, CHCHD2, CIND-PD: Cognitive Impairment in Parkinson's Disease, Clinical Symptoms and Time Course of Parkinson’s Disease Progression, Complications of Dopaminergic Therapies for Parkinson’s Disease, Deep Brain Stimulation (DBS), Dementia in Parkinson's Disease, Department of Human Protein Sciences: Geneva University Hospitals, Department of Neurology: Geneva University Hospitals, DNAJC13, Dopamine, Dopamine Replacement Therapy (DRT), Dreaming in Dementia: REM Sleep Behaviour Disorder and Synucleinopathy, Drug Treatments for Parkinson’s Disease, Early Parkinson Disease, Edmond J Safra Program in Parkinson’s Disease: Toronto Western Hospital, EIF4G1, Faculty of Medicine: Geneva University Hospitals, Falls in Parkinson's Disease, Genetics of Parkinson's Disease, Geneva University Hospitals, Institute of Neurological Sciences in Glasgow, α-Synuclein, α-Synuclein Aggregation, Lancet, Lewy Body Parkinson Disease, LRRK2, LRRK2: Leucine-Rich Repeat Kinase 2 Gene, Monogenic Forms of Parkinson’s Disease (By Gene), Morton and Gloria Shulman Movement Disorders Clinic: Toronto Western Hospital, National Deep Brain Stimulation Service for Scotland, National Service in Scotland: NHS DBS Centres in Scotland, National Specialist Services Committee (Scotland), Neuroproteomics Group: Geneva University Hospitals, NHS DBS Centres in England, Non-Motor Fluctuations in Parkinson's Disease, Parkin (PARK2), Parkinson's Awareness Week, Parkinson’s Awareness Week (2015), Parkinson’s Disease Awareness Week (2015), Parkinson’s Disease Dementia, Parkinson’s Disease Diagnosis, Parkinson’s Disease Pathogenesis, Parkinson’s UK, Parkinson’s UK (Parkinsons Disease Society), Parkinson’s-Like Symptoms, Parkinsonian Symptoms, Parkinsonism, PDD: Parkinson's Disease with Dementia, Prion Diseases, Prion Protein, Proteomic Profiling of Parkinson's Disease-Relevant Brain Regions, Proteomics, Rapid Eye Movement (REM) Sleep Behaviour Disorder, Rapid Eye Movement (REM) Sleep Disorder, Rapid Eye Movement Sleep Behaviour Disorder (RBD), RBD: Rapid Eye Movement Sleep Behaviour Disorder, SNCA, SNCA: α-Synuclein Gene, Switzerland, Synucleinopathies, Synucleinopathy, Toronto Western Hospital, Translational Proteomics, UK Parkinson’s Disease Society Brain Bank Clinical Diagnostic Criteria, University Medical Center: Geneva University Hospitals, University of Toronto, VPS35
Leave a comment
Parkinson’s Disease Awareness Week 2015 (Parkinson’s UK / BBC News)
Summary Parkinson’s Awareness Week 2015 will be April 20th – 26th 2015. This year’s campaign encourages people, everywhere, to be more friendly, patient and forgiving. See the Parkinson’s UK website, at Parkinson’s Awareness Week 2015, to learn more about this … Continue reading
Posted in Charitable Bodies, For Carers (mostly), For Nurses and Therapists (mostly), For Social Workers (mostly), In the News, Management of Condition, National, Parkinson's Disease, Patient Information, Person-Centred Care, Practical Advice, Quick Insights, UK, Universal Interest
Tagged Age-Friendly Cities, Age-Friendly Cities and Communities, Age-Friendly Communities, Age-Friendly Environments, Awareness and Campaigns, Awareness and Understanding, Awareness Campaigns, Awareness of Relationships, Awareness Raising, BBC Health News, Building Dementia and Age-Friendly Neighbourhoods, Compassion, Compassion and Care, Compassion in Care, Compassionate Care, Culture of Compassionate Care, Dementia and Age-Friendly Neighbourhoods, Empathic Curiosity, Empathy, Empathy and Understanding, Friendliness, Hostility, Intelligent Kindness: More Than Basic Care, Kindness, Parkinson's Awareness Week, Parkinson’s Awareness Week (2015), Parkinson’s Disease Awareness Week (2015), Parkinson’s UK, Parkinson’s UK (Parkinsons Disease Society), Public Rudeness, Reducing Stigma, Stigma, Symptom Awareness and Campaigns, Tolerance, Up Your Friendly Challenge: Parkinson’s Awareness Week (2015)
Leave a comment
